efficacy of Fumitory in chronic urticaria
Phase 3
- Conditions
- chronic urticaria.Other urticaria Urticaria: chronic recurrent periodic
- Registration Number
- IRCT2015112825275N1
- Lead Sponsor
- Vice Chancellor for research of Traditional Medicine Faculity of Tehran university of medical scienc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
patients with chronic urticaria with doctor confirmation, 12 to 70 years old, male and female, have tendency for entering into study
Exclusion criteria:
Using topical corticosteroid during the past week, Using oral corticosteroid during the past week, using antihistamines within last four days, pregnancy & Breast-feeding, having severe angioedema, having uncontrolled cardiovascular, respiratory , hematologic, urology, immune system & Connective tissue diseases, having sensitivity to Cetirizine, having sensivity to fumitory plant, history of Seizure, history of rising intraocular pressure, incidence of side effects, Unwillingness to continue this study; Unable to follow up the patient regularly
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quantity of hives. Timepoint: The First,third and fourth weeks of study. Method of measurement: Urticaria Activity Score (UAS) questionnaire.;Level of itch. Timepoint: The First, Third and fourth weeks of study. Method of measurement: Urticaria Activity Score (UAS) questionnaire.;Quality of life. Timepoint: The First,third and fourth weeks of study. Method of measurement: Quality of Life Questionnaire of chronic urticaria CU-Q2oL.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: The first, third and fourth weeks of study. Method of measurement: common Terminology Criteria for Adverse Events v4.0 2009 questionnaire.